0001209191-22-033627.txt : 20220602
0001209191-22-033627.hdr.sgml : 20220602
20220602171211
ACCESSION NUMBER: 0001209191-22-033627
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220601
FILED AS OF DATE: 20220602
DATE AS OF CHANGE: 20220602
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kornfeld Steven
CENTRAL INDEX KEY: 0001814653
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38052
FILM NUMBER: 22991902
MAIL ADDRESS:
STREET 1: C/O FORTE BIOSCIENCES, INC.
STREET 2: 1124 W. CARSON ST., MRL BLDG 3-320
CITY: TORRANCE
STATE: CA
ZIP: 90502
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Forte Biosciences, Inc.
CENTRAL INDEX KEY: 0001419041
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261243872
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1124 W CARSON STREET
STREET 2: MRL BUILDING 3-320
CITY: TORRANCE
STATE: CA
ZIP: 90502
BUSINESS PHONE: (310) 618-6994
MAIL ADDRESS:
STREET 1: 1124 W CARSON STREET
STREET 2: MRL BUILDING 3-320
CITY: TORRANCE
STATE: CA
ZIP: 90502
FORMER COMPANY:
FORMER CONFORMED NAME: Tocagen Inc
DATE OF NAME CHANGE: 20071120
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-01
0
0001419041
Forte Biosciences, Inc.
FBRX
0001814653
Kornfeld Steven
C/O FORTE BIOSCIENCES, INC.
3060 PEGASUS PARK DR., BUILDING 6
DALLAS
TX
75247
1
0
0
0
Stock Option (right to buy)
1.27
2022-06-01
4
A
0
25000
0.00
A
2032-06-01
Common Stock
25000
25000
D
Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, the shares subject to the option shall vest in equal monthly installments over the twelve (12) months following the Date of Grant, provided that the shares subject to the option shall be fully vested on the date of the Issuer's next annual stockholder meeting. "Date of Grant" shall mean June 1, 2022.
/s/ Paul A. Wagner, Ph.D., as Attorney-in-Fact
2022-06-02